A Phase I study to evaluate the safety, tolerability, and pharmacokinetics of NTX-083 in healthy adult males.

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2025
This article has no abstract
Epistemonikos ID: aaf0eea5c6af1c91006dba33686e5d3f37f7a2aa
First added on: Apr 22, 2026